{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:53:22Z","timestamp":1765486402616,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.antiviral.2020.104753","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T02:32:03Z","timestamp":1582770723000},"page":"104753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus"],"prefix":"10.1016","volume":"180","author":[{"given":"Hongyu","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Bart","family":"Tarbet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Salih","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Carnelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Pronyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantha","family":"Kodihalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","series-title":"xMAP Cook Book: A Collection of Methods and Protocols for Developing Multiplex Assays with xMAP Technology","author":"Angeloni","key":"10.1016\/j.antiviral.2020.104753_bib1"},{"key":"10.1016\/j.antiviral.2020.104753_bib2","first-page":"803","article-title":"Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes","volume":"28","author":"Bonilla","year":"2008","journal-title":"Immunol. Allergy Clin."},{"key":"10.1016\/j.antiviral.2020.104753_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003495-200060010-00004","article-title":"Humoral immune response to influenza vaccination in patients from high risk groups","volume":"60","author":"Brydak","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2020.104753_bib4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S1473-3099(14)70960-0","article-title":"Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case\u2013control studies","volume":"14","author":"Darvishian","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104753_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/dmd.106.011734","article-title":"Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates","volume":"35","author":"Datta-Mannan","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2020.104753_bib6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-2600(19)30253-X","article-title":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomized, placebo-controlled trial","volume":"7","author":"Davey","year":"2019","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.antiviral.2020.104753_bib7","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/jmv.24911","article-title":"The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus","volume":"89","author":"Fage","year":"2017","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104753_bib8","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP)","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.antiviral.2020.104753_bib9","first-page":"10","article-title":"Early estimates of seasonal influenza vaccine effectiveness-United States","volume":"64","author":"Flannery","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2020.104753_bib10","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.vaccine.2015.02.042","article-title":"Deaths averted by influenza vaccination in the U.S. during the seasons2005\/06 through 2013\/14","volume":"33","author":"Foppa","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104753_bib11","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices-United States, 2013-14","volume":"62","author":"Grohskopf","year":"2013","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.antiviral.2020.104753_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.15585\/mmwr.mm6430a3","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2015\u201316 influenza season","volume":"64","author":"Grohskopf","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2020.104753_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104753_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40265-018-0899-1","article-title":"Baloxavir: first global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2020.104753_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104753_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1378\/chest.12-2907","article-title":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","volume":"144","author":"Hung","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.antiviral.2020.104753_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1586\/14787210.4.5.795","article-title":"Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors","volume":"4","author":"Hurt","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2020.104753_bib18","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.1128\/JVI.00159-10","article-title":"Adaptation of pandemic H1N1 influenza viruses in mice","volume":"84","author":"Ilyushina","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2020.104753_bib19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S2213-2600(19)30265-6","article-title":"Passive immunity for the treatment of influenza: quality not quantity","volume":"7","author":"Kanjilal","year":"2019","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.antiviral.2020.104753_bib20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1537-2995.2011.03347.x","article-title":"Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza","volume":"52","author":"Kreil","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.antiviral.2020.104753_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/irv.12187","article-title":"Peramivir and laninamivir susceptibility of circulating influenza A and B viruses","volume":"8","author":"Leang","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.antiviral.2020.104753_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijid.2016.01.001","article-title":"Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010-2011 influenza season in Russia","volume":"43","author":"Leneva","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104753_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2020.104753_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2020.104753_bib25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Luliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104753_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/irv.12258","article-title":"Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status","volume":"8","author":"Matias","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.antiviral.2020.104753_bib27","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/jac\/dkt205","article-title":"Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase","volume":"68","author":"McKimm-Breschkin","year":"2013","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104753_bib28","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1097\/INF.0b013e318168b739","article-title":"Antivirals and influenza: frequency of resistance","volume":"27","author":"Monto","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2020.104753_bib29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104753_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1177127","article-title":"Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets","volume":"325","author":"Munster","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104753_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrg2053","article-title":"The evolution of epidemic influenza","volume":"8","author":"Nelson","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2020.104753_bib32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/irv.12273","article-title":"Chimeric antibodies with extended half-life in ferrets","volume":"8","author":"Nesspor","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.antiviral.2020.104753_bib33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/CCM.0b013e318236f486","article-title":"The use of hyerimmune serum for severe influenza infections","volume":"40","author":"Rockman","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.antiviral.2020.104753_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ebiom.2017.04.010","article-title":"Intravenous immunoglobulin protects against severe pandemic influenza infection","volume":"19","author":"Rockman","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.antiviral.2020.104753_bib35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104753_bib36","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","article-title":"Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier","volume":"33","author":"St-Amour","year":"2013","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.antiviral.2020.104753_bib37","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/s41467-019-11249-y","article-title":"Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104753_bib38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"92","author":"Thompson","year":"2004","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2020.104753_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/19420862.2015.1113360","article-title":"Pharmacokinetic properties of IgG and various Fc fusion proteins in mice","volume":"8","author":"Unverdorben","year":"2015","journal-title":"mAbs"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2020.104753_bib40","article-title":"Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic","volume":"55","author":"Ward","year":"2005","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104753_bib41","series-title":"Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza. Geneva.","isbn-type":"print","article-title":"Part 2. The laboratory diagnosis and virological surveillance of influenza","author":"World Health Organization (WHO) Global Influence Surveillance Network","year":"2011","ISBN":"https:\/\/id.crossref.org\/isbn\/9789241548090"},{"key":"10.1016\/j.antiviral.2020.104753_bib42","doi-asserted-by":"crossref","first-page":"17735","DOI":"10.1038\/s41598-017-17986-8","article-title":"Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies","volume":"7","author":"Yasuhara","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104753_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2217\/imt.11.167","article-title":"Passive immune neutralization strategies for prevention and control of influenza A infections","volume":"4","author":"Ye","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.antiviral.2020.104753_bib44","first-page":"3905","article-title":"Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in\u00a0vivo half-life","volume":"58","author":"Zuckier","year":"1998","journal-title":"Canc. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:31Z","timestamp":1759062751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":44,"alternative-id":["S0166354219304875"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104753","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104753"}}